233 related articles for article (PubMed ID: 22992788)
21. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
Hong M; Zhang X; Hu Y; Wang H; He W; Mei H; Yu J; Guo T; Song S
Thromb Res; 2009; 123(3):556-64. PubMed ID: 18620739
[TBL] [Abstract][Full Text] [Related]
22. Identification of the biomarkers for the prediction of efficacy in first-line chemotherapy of metastatic colorectal cancer patients using SELDI-TOF-MS and artificial neural networks.
Yuan Y; Tan CW; Shen H; Yu JK; Fang XF; Jiang WZ; Zheng S
Hepatogastroenterology; 2012; 59(120):2461-5. PubMed ID: 22497949
[TBL] [Abstract][Full Text] [Related]
23. [Serum diagnosis of head and neck squamous cell carcinoma using surface-enhanced desorption ionization mass spectrometry and artificial neural network analyses].
Cao SM; Guo X; Chen FJ; Yang AK; Chen WK; Li NW
Ai Zheng; 2007 Jul; 26(7):767-70. PubMed ID: 17626756
[TBL] [Abstract][Full Text] [Related]
24. Detection and significance of serum protein markers of small-cell lung cancer.
Han M; Liu Q; Yu J; Zheng S
J Clin Lab Anal; 2008; 22(2):131-7. PubMed ID: 18348318
[TBL] [Abstract][Full Text] [Related]
25. Identification of serum biomarkers for nasopharyngeal carcinoma by proteomic analysis.
Wei YS; Zheng YH; Liang WB; Zhang JZ; Yang ZH; Lv ML; Jia J; Zhang L
Cancer; 2008 Feb; 112(3):544-51. PubMed ID: 18085639
[TBL] [Abstract][Full Text] [Related]
26. Proteomic studies of early-stage and advanced ovarian cancer patients.
Wang J; Zhang X; Ge X; Guo H; Xiong G; Zhu Y
Gynecol Oncol; 2008 Oct; 111(1):111-9. PubMed ID: 18703221
[TBL] [Abstract][Full Text] [Related]
27. Application of serum protein fingerprinting coupled with artificial neural network model in diagnosis of hepatocellular carcinoma.
Wang JX; Zhang B; Yu JK; Liu J; Yang MQ; Zheng S
Chin Med J (Engl); 2005 Aug; 118(15):1278-84. PubMed ID: 16117882
[TBL] [Abstract][Full Text] [Related]
28. [Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique].
Ma N; Ge CL; Luan FM; Hu CJ; Li YZ; Liu YF
Zhonghua Wai Ke Za Zhi; 2008 Jun; 46(12):932-5. PubMed ID: 19035154
[TBL] [Abstract][Full Text] [Related]
29. Distinctive potentiating effects of cisplatin and/or ifosfamide combined with etoposide in human small cell lung carcinoma xenografts.
Nemati F; Livartowski A; De Cremoux P; Bourgeois Y; Arvelo F; Pouillart P; Poupon MF
Clin Cancer Res; 2000 May; 6(5):2075-86. PubMed ID: 10815935
[TBL] [Abstract][Full Text] [Related]
30. [Detection and clinical significance of serum proteomic patterns of breast cancers by surface enhanced laser desorption/ionization time of flight mass spectrometry].
Zhang GQ; Du J; Pang D
Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):204-7. PubMed ID: 16875606
[TBL] [Abstract][Full Text] [Related]
31. [Application of serum proteomic mass spectrum analysis in breast cancer].
Ying MG; Chen Q; Ye YB; Chen HJ; Chen X; Zheng HY; Wu F
Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):698-702. PubMed ID: 21122387
[TBL] [Abstract][Full Text] [Related]
32. [Application of SELDI-TOF-MS in establishing a model for predicting radiotherapy response of hypopharyngeal cancers].
Tian WD; Zeng ZY; Yu WB; Li XP
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Jun; 30(6):1282-7. PubMed ID: 20584658
[TBL] [Abstract][Full Text] [Related]
33. [Use of laser capture microdissection and surface-enhanced laser desorption ionization time-of-flight mass spectrometry to screen differential proteins in lung adenocarcinoma and lung squamous carcinoma].
Tian YX; Yang SY; Nan YD; Zhang W; Zhou B; Bu LN; Huo SF; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(3):145-8. PubMed ID: 18361807
[TBL] [Abstract][Full Text] [Related]
34. [Dynamic changes of serum proteomic spectra in patients with non-Hodgkin's lymphoma (NHL) before and after chemotherapy and screening of candidate biomarkers for NHL].
Ling JY; Sun XF; Zhang X; Zhen ZJ; Xia Y; Luo WB; Lin H; Zheng L
Ai Zheng; 2008 Oct; 27(10):1065-9. PubMed ID: 18851786
[TBL] [Abstract][Full Text] [Related]
35. Using proteomic approaches to identify new biomarkers for detection and monitoring of ovarian cancer.
Kong F; Nicole White C; Xiao X; Feng Y; Xu C; He D; Zhang Z; Yu Y
Gynecol Oncol; 2006 Feb; 100(2):247-53. PubMed ID: 16229881
[TBL] [Abstract][Full Text] [Related]
36. New potential biomarkers in the diagnosis of esophageal squamous cell carcinoma.
Xu SY; Liu Z; Ma WJ; Sheyhidin I; Zheng ST; Lu XM
Biomarkers; 2009 Aug; 14(5):340-6. PubMed ID: 19552569
[TBL] [Abstract][Full Text] [Related]
37. [Application of serum protein fingerprint model and support vector machine in diagnosis of thyroid cancer].
Wang JX; Wang L; Fan YZ; Liu QL; Zhang J; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):979-82. PubMed ID: 16759540
[TBL] [Abstract][Full Text] [Related]
38. [Detecting biomarkers from serum in nephroblastoma patients with support vector machine].
Wang JX; Zhang J; Liu QL; Wang L; Fan YZ; Yu JK; Zheng S
Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(42):2982-5. PubMed ID: 17288811
[TBL] [Abstract][Full Text] [Related]
39. Serum protein profile analysis in patients with head and neck squamous cell carcinoma.
Gourin CG; Xia ZS; Han Y; French AM; O'Rourke AK; Terris DJ; Adam BL
Arch Otolaryngol Head Neck Surg; 2006 Apr; 132(4):390-7. PubMed ID: 16618908
[TBL] [Abstract][Full Text] [Related]
40. [Application of serum protein pattern model in diagnosis of colorectal cancer].
Chen YD; Zheng S; Yu JK; Hu X
Zhonghua Zhong Liu Za Zhi; 2004 Jul; 26(7):417-20. PubMed ID: 15355647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
